Stock ScreenerStock IdeasStrong Buys According to Wall StreetStrong Buys According to Wall StreetCompanies with high upside and a consensus strong buy recommendation from Wall Street analysts
Stock ScreenerStock IdeasStrong Buys According to Wall Street
Consensus: Strong Buy
Analysts: >= 3
Upside/Downside: Large Upside
| Ticker | Company | Performance Score | Market Cap | Revenue | EBITDA | Earnings | EPS | Revenue Growth Y/Y | Revenue Growth 5Y | Earnings Growth Y/Y | Earnings Growth 5Y | Earnings Date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HLVX | HILLEVAX INC | $676.43M | $0.00 | -$119.02M | -$123.57M | -$3.04 | N/A | N/A | N/A | N/A | 2024-06-05 | |
| DNLI | DENALI THERAPEUTICS INC | $2.39B | $330.53M | -$128.47M | -$145.22M | -$1.06 | 204.74% | 20.67% | N/A | N/A | 2024-05-06 | |
| ANGI | ANGI INC | $1.28B | $1.36B | $94.48M | -$40.94M | -$0.06 | -22.99% | 3.71% | N/A | N/A | 2024-05-07 | |
| TTGT | TECHTARGET INC | $799.31M | $229.96M | $23.90M | $4.46M | $0.16 | -22.70% | 13.64% | -88.65% | -19.39% | 2024-05-09 | |
| NR | NEWPARK RESOURCES INC | $604.93M | $718.68M | $66.32M | $16.19M | $0.20 | -14.36% | -5.04% | N/A | -7.16% | ||
| ACHV | ACHIEVE LIFE SCIENCES INC | $162.18M | $0.00 | -$26.73M | -$29.82M | -$1.50 | N/A | N/A | N/A | N/A | 2024-06-06 | |
| EYPT | EYEPOINT PHARMACEUTICALS INC | $983.66M | $46.02M | -$69.00M | -$70.80M | -$1.82 | 11.14% | 58.70% | N/A | N/A |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.